Fig. 3. Results of meta-analysis comparing cannabis to placebo intervention for neuropathic pain patients. Subgroup analyses for differences of change in pain intensity from baseline for (a) THC and THC/CBD studies and (b) CBD and synthetic cannabis interventions; (c) Percent reduction in pain intensity with THC. A p ≤ 0.05 denotes a statistically significant difference. CBD, cannabidiol; CBDV, cannabidivarin; CI, confidence interval; THC, tetrahydrocannabinol.
